| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 37.40B | 37.75B | 36.57B | 34.08B | 31.68B | 29.04B |
| Gross Profit | 15.45B | 15.80B | 16.96B | 34.08B | 31.68B | 14.97B |
| EBITDA | -15.52B | 11.30B | 12.01B | 14.45B | 12.35B | 9.98B |
| Net Income | 3.94B | 3.89B | 6.30B | 6.38B | 5.90B | 5.03B |
Balance Sheet | ||||||
| Total Assets | 363.80B | 360.39B | 351.48B | 346.99B | 335.88B | 299.93B |
| Cash, Cash Equivalents and Short-Term Investments | 21.30B | 34.20B | 22.07B | 19.67B | 19.63B | 15.15B |
| Total Debt | 266.30B | 265.91B | 256.62B | 251.83B | 230.81B | 206.04B |
| Total Liabilities | 304.32B | 302.91B | 293.91B | 294.55B | 282.83B | 254.66B |
| Stockholders Equity | 51.00B | 48.99B | 51.67B | 48.33B | 49.04B | 42.60B |
Cash Flow | ||||||
| Free Cash Flow | 3.10B | 1.55B | 1.17B | -11.64B | -25.33B | -31.64B |
| Operating Cash Flow | 9.15B | 9.97B | 3.73B | -7.69B | -14.87B | -24.46B |
| Investing Cash Flow | -1.92B | -3.54B | -2.40B | -1.77B | -9.85B | -10.55B |
| Financing Cash Flow | -11.99B | -5.60B | 1.59B | 9.61B | 28.52B | 42.94B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | HK$680.00M | 6.20 | 8.46% | 5.46% | -24.04% | 60.24% | |
74 Outperform | HK$20.35B | 3.75 | 13.09% | 5.84% | 3.17% | 23.13% | |
71 Outperform | HK$6.34B | 4.24 | 7.87% | 11.28% | 0.59% | -5.95% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | HK$34.34B | 7.32 | 7.90% | 6.69% | -1.77% | -24.74% | |
64 Neutral | HK$1.37B | 3.78 | 9.89% | 7.43% | 1.11% | 3.98% | |
59 Neutral | HK$290.84M | 21.00 | 0.49% | ― | 8.77% | -76.88% |
Far East Horizon Limited has scheduled a board meeting for 11 March 2026 to review and approve the group’s audited final results for the financial year ended 31 December 2025. At the same meeting, the board will consider recommending a final dividend for shareholders, signalling an upcoming disclosure of the company’s full-year financial performance and potential cash return to investors, which will be closely watched by the market for indications of its earnings strength and capital allocation strategy.
The most recent analyst rating on (HK:3360) stock is a Hold with a HK$8.50 price target. To see the full list of analyst forecasts on Far East Horizon Limited stock, see the HK:3360 Stock Forecast page.
Far East Horizon Limited, a company incorporated in Hong Kong, has designated Mr. Liu Jialin as the lead independent non-executive director to enhance corporate governance. This change aligns with amendments to the Listing Rules and the Corporate Governance Code, aiming to improve board effectiveness and communication with shareholders.
The most recent analyst rating on (HK:3360) stock is a Hold with a HK$8.50 price target. To see the full list of analyst forecasts on Far East Horizon Limited stock, see the HK:3360 Stock Forecast page.
Far East Horizon Limited has announced the composition of its board of directors, highlighting key roles and responsibilities. The board comprises executive, non-executive, and independent non-executive directors, with Mr. KONG Fanxing serving as Chairman and CEO. The company has also established four committees: Audit and Risk Management, Remuneration and Nomination, Strategy and Investment, and Environmental, Social and Governance, each with designated chairpersons and members. This organizational structure aims to enhance corporate governance and strategic oversight, potentially impacting the company’s operational effectiveness and stakeholder confidence.
The most recent analyst rating on (HK:3360) stock is a Hold with a HK$8.50 price target. To see the full list of analyst forecasts on Far East Horizon Limited stock, see the HK:3360 Stock Forecast page.
Far East Horizon Limited announced a drawdown of HKD350,000,000 under its US$4 billion Medium Term Note and Perpetual Securities Programme. The proceeds from this issuance, rated BBB- by S&P, will be used for working capital and general corporate purposes, with potential on-lending to its subsidiaries in the PRC, pending necessary approvals.
The most recent analyst rating on (HK:3360) stock is a Hold with a HK$8.50 price target. To see the full list of analyst forecasts on Far East Horizon Limited stock, see the HK:3360 Stock Forecast page.
Far East Horizon Limited announced a drawdown of JPY8,000,000,000 under its Medium Term Note and Perpetual Securities Programme. The proceeds from this issuance, which is aimed at professional investors, will be used to finance and refinance green and social projects, aligning with the company’s sustainable financing framework.
The most recent analyst rating on (HK:3360) stock is a Hold with a HK$7.50 price target. To see the full list of analyst forecasts on Far East Horizon Limited stock, see the HK:3360 Stock Forecast page.
Far East Horizon Limited reported a year-on-year increase in profit attributable to ordinary shareholders for the first three quarters of 2025, driven by steady growth in its financial business. The company maintained robust asset quality and saw significant expansion in its inclusive finance segment, with interest-earning assets increasing by over 60% year-on-year. Despite a decline in revenue for Horizon Healthcare, the group remained profitable overall. The company’s effective risk management strategies ensured a stable liquidity position, and it continues to focus on its ‘finance + industry’ development strategy to enhance shareholder returns.
The most recent analyst rating on (HK:3360) stock is a Hold with a HK$7.50 price target. To see the full list of analyst forecasts on Far East Horizon Limited stock, see the HK:3360 Stock Forecast page.